» Articles » PMID: 22457777

Molecular Characterisation of Transport Mechanisms at the Developing Mouse Blood-CSF Interface: a Transcriptome Approach

Overview
Journal PLoS One
Date 2012 Mar 30
PMID 22457777
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Exchange mechanisms across the blood-cerebrospinal fluid (CSF) barrier in the choroid plexuses within the cerebral ventricles control access of molecules to the central nervous system, especially in early development when the brain is poorly vascularised. However, little is known about their molecular or developmental characteristics. We examined the transcriptome of lateral ventricular choroid plexus in embryonic day 15 (E15) and adult mice. Numerous genes identified in the adult were expressed at similar levels at E15, indicating substantial plexus maturity early in development. Some genes coding for key functions (intercellular/tight junctions, influx/efflux transporters) changed expression during development and their expression patterns are discussed in the context of available physiological/permeability results in the developing brain. Three genes: Secreted protein acidic and rich in cysteine (Sparc), Glycophorin A (Gypa) and C (Gypc), were identified as those whose gene products are candidates to target plasma proteins to choroid plexus cells. These were investigated using quantitative- and single-cell-PCR on plexus epithelial cells that were albumin- or total plasma protein-immunopositive. Results showed a significant degree of concordance between plasma protein/albumin immunoreactivity and expression of the putative transporters. Immunohistochemistry identified SPARC and GYPA in choroid plexus epithelial cells in the embryo with a subcellular distribution that was consistent with transport of albumin from blood to cerebrospinal fluid. In adult plexus this pattern of immunostaining was absent. We propose a model of the cellular mechanism in which SPARC and GYPA, together with identified vesicle-associated membrane proteins (VAMPs) may act as receptors/transporters in developmentally regulated transfer of plasma proteins at the blood-CSF interface.

Citing Articles

Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood-Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery.

Madadi A, Sohn M Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204177 PMC: 11357388. DOI: 10.3390/ph17081070.


Enhancing of cerebral Abeta clearance by modulation of ABC transporter expression: a review of experimental approaches.

Loeffler D Front Aging Neurosci. 2024; 16:1368200.

PMID: 38872626 PMC: 11170721. DOI: 10.3389/fnagi.2024.1368200.


The anatomic basis of leptomeningeal metastasis.

Freret M, Boire A J Exp Med. 2024; 221(4).

PMID: 38451255 PMC: 10919154. DOI: 10.1084/jem.20212121.


The development and function of the brain barriers - an overlooked consideration for chemical toxicity.

Bell K, OShaughnessy K Front Toxicol. 2022; 4:1000212.

PMID: 36329715 PMC: 9622783. DOI: 10.3389/ftox.2022.1000212.


The choroid plexus: a missing link in our understanding of brain development and function.

Saunders N, Dziegielewska K, Fame R, Lehtinen M, Liddelow S Physiol Rev. 2022; 103(1):919-956.

PMID: 36173801 PMC: 9678431. DOI: 10.1152/physrev.00060.2021.


References
1.
Liddelow S, Dziegielewska K, Mollgard K, Phoenix T, Temple S, Vandeberg J . SPARC/osteonectin, an endogenous mechanism for targeting albumin to the blood-cerebrospinal fluid interface during brain development. Eur J Neurosci. 2011; 34(7):1062-73. DOI: 10.1111/j.1460-9568.2011.07821.x. View

2.
Morgan E, Moos T . Mechanism and developmental changes in iron transport across the blood-brain barrier. Dev Neurosci. 2002; 24(2-3):106-13. DOI: 10.1159/000065699. View

3.
Bauer H, Traweger A, Zweimueller-Mayer J, Lehner C, Tempfer H, Krizbai I . New aspects of the molecular constituents of tissue barriers. J Neural Transm (Vienna). 2010; 118(1):7-21. DOI: 10.1007/s00702-010-0484-6. View

4.
Ek C, Dziegielewska K, Habgood M, Saunders N . Barriers in the developing brain and Neurotoxicology. Neurotoxicology. 2011; 33(3):586-604. DOI: 10.1016/j.neuro.2011.12.009. View

5.
Porterfield S, HENDRICH C . Tissue iodothyronine levels in fetuses of control and hypothyroid rats at 13 and 16 days gestation. Endocrinology. 1992; 131(1):195-200. DOI: 10.1210/endo.131.1.1611997. View